Roche is teaming up with two medical tech companies to develop an automated insulin delivery system, the first steps towards an ‘artificial pancreas.’ The Swiss pharma will work with existing ...

Continuous Glucose Monitoring market poised for significant growth, driven by advancements in diabetes management and rising global prevalence.

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an attorney said. Scott Whitaker sent a letter to the HHS calling for staff cuts ...